Netherlands· NL-da15293bdedb
Scintimun, 1mg kit voor radiofarmaceutisch preparaat
A 99mtc-technetium-antigranulozyten antikörper product containing besilesomab, registered in Netherlands by Telix Innovations S.A.. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-antigranulozyten antikörper is registered in 9 of 19 countries.
Countries holding a registration under ATC V09HA03 (99mtc-technetium-antigranulozyten antikörper), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
99mtc-technetium-antigranulozyten antikörper · ATC V09HA03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BESILESOMAB
- Manufacturer
- Telix Innovations S.A.
- Country
- Netherlands (NL)
- ATC code
- V09HA03
- ATC class
- 99mTc-Technetium-Antigranulozyten Antikörper
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/09/602
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
99mtc-technetium-antigranulozyten antikörper in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceSCINTIMUN 1 mg trousse pour préparation radiopharmaceutiqueTELIX INNOVATIONS (BELGIQUE)
- CzechiaSCINTIMUNTelix Innovations, Herstal
- SwitzerlandScintimun, Markierungsbesteckb.e.imaging.ag
- SpainSCINTIMUN 1 mg, EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICATelix Innovations
- FinlandScintimunTelix Innovations
- United KingdomScintimun 1mg kit for radiopharmaceutical preparationCurium Pharma UK Ltd
- IrelandScintimun 1 mg kit for radiopharmaceutical preparationTelix Innovations
- IcelandScintimunTelix Innovations
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scintimun
- Liechtenstein · Scintimun
- Norway · Scintimun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffb47b00-8258-443f-b709-4e5a0d1788a1 GET /v1/drugs/ffb47b00-8258-443f-b709-4e5a0d1788a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kit voor radiofarmaceutisch preparaat",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/scintimun-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Technetium (99m Tc) Antigranulocyte Antibody",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp103272",
"excipients": [
"1,1,3,3-PROPAANTETRAFOSFONAAT TETRANATRIUM 2-WATER",
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"NATRIUMDIWATERSTOFFOSFAAT 0-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"SORBITOL (E 420)",
"STIKSTOF (HEAD SPACE) (E 941)",
"STIKSTOF (HEAD SPACE) (E 941)",
"TINDICHLORIDE 2-WATER (E 512)",
"ZOUTZUUR (E 507)"
],
"substances": [
"BESILESOMAB"
],
"leaflet_url": null,
"authorised_at": "2010/01/11",
"procedure_number": "EMEA/H/C/001045",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/09/602",
"additional_monitoring": "N"
}See everything about 99mtc-technetium-antigranulozyten antikörper.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.